How Ketamine Spawned a $1.7 Billion J&J Blockbuster Drug

Johnson & Johnson developed a blockbuster drug based on ketamine, generating $1.7 billion in revenue. The drug's success highlights ketamine's transformation from an anesthetic to a therapeutic treatment for depression.